Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy
Clobazam adjunctive therapy is effective, safe and well tolerated in pediatric patients with drug-resistant epilepsy.
Authors
- Xuejuan Li (ORCID: https://orcid.org/0000-0002-2776-396X)
- Shunan Chen
- Suhong Wang (ORCID: https://orcid.org/0000-0001-9526-9843)
- Lingyan Yu (ORCID: https://orcid.org/0000-0001-7828-139X)
- Yani Hu
- Haibin Dai (ORCID: https://orcid.org/0000-0002-5768-2714)
- Zhenwei Yu (ORCID: https://orcid.org/0000-0002-3776-2290)
- Yuting Fang (ORCID: https://orcid.org/0000-0002-7829-4542)
- Zhou Zhang (ORCID: https://orcid.org/0009-0000-6907-3062)
- Fengqian Mao
Institutions
- University of Science and Technology of China (CN)
- Wenzhou Medical University (CN)
- Sir Run Run Shaw Hospital (CN)
- Anhui Provincial Hospital (CN)
- Shenzhen Children's Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/dddt.s560731
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00